Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Non-small-cell lung cancer mRNA expression signature predicting response to adjuvant chemotherapy.

× No keyword cloud information.

10 in total

1. A lung cancer molecular prognostic test ready for prime time.

Authors: Yang Xie; John D Minna
Journal: Lancet Date: 2012-03-03 Impact factor: 79.321

Review 2. Advances in adjuvant systemic therapy for non-small-cell lung cancer.

Authors: David Leong; Rajat Rai; Brandon Nguyen; Andrew Lee; Desmond Yip
Journal: World J Clin Oncol Date: 2014-10-10

3. Adaptive prediction model in prospective molecular signature-based clinical studies.

Authors: Guanghua Xiao; Shuangge Ma; John Minna; Yang Xie
Journal: Clin Cancer Res Date: 2013-12-09 Impact factor: 12.531

4. Improving the pathologic evaluation of lung cancer resection specimens.

Authors: Raymond U Osarogiagbon; Holly L Hilsenbeck; Elizabeth W Sales; Allen Berry; Robert W Jarrett; Christopher S Giampapa; Clara N Finch-Cruz; David Spencer
Journal: Transl Lung Cancer Res Date: 2015-08

5. HDGF and ADAM9 are novel molecular staging biomarkers, prognostic biomarkers and predictive biomarkers for adjuvant chemotherapy in surgically resected stage I non-small cell lung cancer.

Authors: Jun Zhang; Ning Chen; Juan Qi; Baosen Zhou; Xueshan Qiu
Journal: J Cancer Res Clin Oncol Date: 2014-04-27 Impact factor: 4.553

Review 6. Adjuvant chemotherapy for resected non-small-cell lung cancer: future perspectives for clinical research.

Authors: Maria Bonomi; Sara Pilotto; Michele Milella; Francesco Massari; Sara Cingarlini; Matteo Brunelli; Marco Chilosi; Giampaolo Tortora; Emilio Bria
Journal: J Exp Clin Cancer Res Date: 2011-12-29

7. Impact of in vitro chemosensitivity test-guided platinum-based adjuvant chemotherapy on the surgical outcomes of patients with p-stage IIIA non-small cell lung cancer that underwent complete resection.

Authors: Yuki Akazawa; Masahiko Higashiyama; Kazumi Nishino; Jyunji Uchida; Toru Kumagai; Takako Inoue; Ayako Fujiwara; Toshiteru Tokunaga; Jiro Okami; Fumio Imamura; Ken Kodama; Hisayuki Kobayashi
Journal: Mol Clin Oncol Date: 2017-07-24

8. [Aberrant expression of HDGF and its prognostic values in surgically resected non-small cell lung cancer].

Authors: Jun Zhang; Juan Qi; Yan Guo; Yi Guo; Weineng Fu; Baosen Zhou; Guangping Wu; Libo Han; Anguang He
Journal: Zhongguo Fei Ai Za Zhi Date: 2011-03

9. Transforming growth factor β-induced epithelial-to-mesenchymal signature predicts metastasis-free survival in non-small cell lung cancer.

Authors: Edna Gordian; Eric A Welsh; Nicholas Gimbrone; Erin M Siegel; David Shibata; Ben C Creelan; William Douglas Cress; Steven A Eschrich; Eric B Haura; Teresita Muñoz-Antonia
Journal: Oncotarget Date: 2019-01-25

10. High expression of a disintegrin and metalloproteinase-9 predicts a shortened survival time in completely resected stage I non-small cell lung cancer.

Authors: Jun Zhang; Juan Qi; Ning Chen; Weineng Fu; Baosen Zhou; Anguang He
Journal: Oncol Lett Date: 2013-02-22 Impact factor: 2.967

10 in total